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Background: Unipolar mania is a putative subtype of bipolar disorder (BD) in which 
individuals experience recurrent manic but not major depressive episodes. Few 
studies of unipolar mania have been conducted in developed countries and none in 
the UK. This study aimed to identify and characterise people with unipolar mania in 
the UK and France. Methods: People with unipolar mania were ascertained using a 
South London UK electronic case register and a French BD case series. Each unipolar 
mania group was compared to a matched group of people with BD who have 
experienced depressive episodes. Results: 17 people with unipolar mania were 
identified in South London and 13 in France. The frequency of unipolar mania as a 
percentage of the BD clinical population was 1.2% for the South London cohort and 
3.3% for the French cohort. In both cohorts, people with unipolar mania experienced 
more manic episodes than people with BD, and in the French cohort were more likely 
to experience a psychotic illness onset and more psychiatric admissions. Treatment 
characteristics of people with unipolar mania were similar to people with BD except 
that the unipolar mania group was less likely to be treated with antidepressants. 
Limitations: The relatively small number of people with unipolar mania identified by 
this study limits its power to detect differences in clinical variables. Conclusions: 
People with unipolar mania can be identified in France and the UK, and they may 
experience a higher frequency of manic episodes but have similar treatment 
characteristics to people with BD.  















Mania is the defining phase of bipolar I disorder. Recent studies indicate that mania 
may be inherited independently to depression and as such mania may be the 
behavioural phenotype of a distinct underlying neurobiological pathway (Merikangas 
et al., 2014). An important way to better understand bipolar disorder, interrogating this 
pathway, would be to dissect the broad bipolar phenotype by investigating people with 
unipolar mania who experience recurrent episodes of mania but not major depressive 
episodes. Investigating the clinical characteristics of people with unipolar mania is also 
important as they may have different care needs and risk profiles compared to people 
with bipolar disorder who also experience depressive episodes. The concept of 
unipolar mania dates back to Kraepelin (Mehta, 2014) although in modern diagnostic 
criteria unipolar mania is conceptualised as a subtype of bipolar I disorder (DSM-5) or 
as bipolar type I disorder, unspecified (ICD-11). Perhaps because of the lack of a 
distinct diagnostic category, there has been a little research into unipolar mania 
particularly in urban populations in developed countries. Most studies have been 
conducted in developing countries where rates of unipolar mania have been reported 
to be much higher than those in developed countries (Yazici, 2014).  
In the past 25 years only six studies have investigated unipolar mania in developed 
countries (Angst et al., 2004; Baek et al., 2014; Douki et al., 2012; Perugi et al., 2007; 
Shulman and Tohen, 1994; Solomon et al., 2003), and none have investigated 
unipolar mania in a United Kingdom population. The studies that are available have 
used differing criteria due to a lack of a consensus unipolar mania definition. Although 
all studies based their definition on the absence of a depressive episode, with some 
additionally excluding people who have experienced mixed episode, criteria differ in 
the minimum number of manic episodes experienced (1 in older studies but 3-4 in 
more recent studies) and duration of required follow-up (minimum of 4-5 years follow-
up or at least 10 years of total illness duration) (Yazici, 2014). The unipolar mania 
studies available from both developed and developing countries indicate that people 
with unipolar mania may have an earlier age of illness onset and experience more 
psychotic symptoms but experience less suicidality and co-morbid anxiety disorders. 
They may also have better outcomes with better social and professional adjustment 
(Yazici, 2014).  
The aim of this study was to identify people with unipolar mania in the United Kingdom 
and France and to characterise their demographic, symptom and treatment profiles. 
Based on previous studies, we hypothesised that people with unipolar mania would 
be more likely to experience a history of psychosis and an earlier age of onset of 
bipolar disorder but would be less likely to experience self-harm or anxiety disorders 





People with unipolar mania were identified and characterised in two populations: a 
retrospective case control series of people with bipolar disorder in the South London 
and Maudsley NHS Foundation Trust (SLaM) Biomedical Research Centre (BRC) 
Case Register, London, UK (Cohort 1) and a case series of French people of 
Caucasian ethnicity with bipolar disorder (Cohort 2). The definition of unipolar mania 
used for both cohorts was: a history of at least three manic episodes, no history of 
depressive or mixed episodes and a duration of illness lasting at least 10 years. This 
criterion is similar to that used by Perugi et al. in a previous unipolar mania study 
(Perugi et al., 2007) but also requires exclusion of people who have experienced at 
least one mixed episode as an additional criterion. We chose to use a minimum 
duration of illness of 10 years as an inclusion criterion, rather than a 4- or 5-year 
duration used in other studies, to increase the stability of diagnosis and minimise the 
likelihood that identified people with unipolar mania will subsequently experience a 
depressive episode. 
Cohort 1 
For the South London cohort, people with unipolar mania and matching bipolar 
disorder controls who have experienced depressive episodes were identified using the 
SLaM BRC Case Register between January 2016 and August 2018. The SLaM BRC 
case register is the largest regional register in Europe with records of over 300,000 
individual cases representing the total secondary care use of mental health services 
for a population of 1.1 million in an urban population located in South London (Perera 
et al., 2016). The Case Register comprises anonymised mental health patient records 
derived from electronic clinical records used across SLaM and is accessed through 
the Clinical Record Interactive Search (CRIS). CRIS allows researchers to search 
against any combination of structured and unstructured fields from electronic clinical 
records (Stewart et al., 2009). A CRIS search automatically captures demographic 
details of identified individuals and supports the manual extraction of clinical variables. 
The resource has previously supported research studies investigating bipolar disorder 
(Patel et al., 2015a; Patel et al., 2015b). The CRIS data resource received ethical 
approval as an anonymised data-set for secondary analyses from Oxfordshire 
research ethics committee (Ref: 08/H0606/71+5) and the study proposal was 
reviewed and approved by the BRC CRIS Oversight committee. 
People with unipolar mania were identified by performing a CRIS search using the 
following criteria: patients diagnosed with ICD-10 diagnosis of a manic episode (F30.0-
9); or bipolar affective disorder, current episode manic or hypomanic (F31.0-2); or 
bipolar affective disorder currently in remission, other bipolar affective disorder, or 
bipolar affective disorder unspecified (F31.7-9); and who had never been diagnosed 
with schizophrenia (F20.0-9), schizoaffective disorders (F25.0-9), depressive 
disorders (F32.0-9, F33.0-9)  or bipolar affective disorder current episode depression 
or mixed (F31.3-6); and who had at least 10 years of clinical follow-up to ensure the 
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10 years of duration of illness. In the identified sample, a keyword search of “Helpless, 
Hopeless, Worthless, Social Withdrawal, Apathy, Low mood, Sad, Tearful, Anhedonia, 
Depression, Depressive, Antidepressant” was conducted in the events and 
correspondence electronic patient record fields. Texts with a keyword hit were then 
read manually to ensure that any depressive episodes and/or symptoms were not 
missed by the CRIS search and that remaining patients with bipolar disorder who had 
experienced depressive episodes or symptoms were excluded.   
People with bipolar disorder who have experienced at least one depressive episode 
and at least 10 years clinical follow-up were matched by age, gender and ethnicity to 
the unipolar mania group. A second CRIS search to identify this comparator group 
was used: patients with at least 10 years follow-up, receiving an ICD-10 diagnosis of 
a manic episode (F30.0-9) or bipolar affective disorder (F31.0-9), and never being 
diagnosed with schizophrenia (F20.0-9) or schizoaffective disorder (F25.0-9). The 
demographic details of this clinical South London bipolar disorder population were 
extracted from automatically generated CRIS data. Patients with bipolar disorder were 
then matched by age (+/-5 years), gender and ethnicity group (white, mixed, Asian or 
Asian British, Black or Black British, other) to individual unipolar mania patients. The 
correspondence and event notes of the possible matches (starting from the nearest 
age and ethnicity match to their unipolar mania counterparts) were manually read to 
ensure the presence of at least one depressive episode and that sufficient clinical 
information was recorded.  
The following variables were identified and extracted by reading the anonymised 
electronic clinical record correspondence and event notes for each unipolar mania and 
matched bipolar disorder patient: date of first and last recorded clinical contact, type 
of report available, current age, gender, ethnicity, year of symptom onset, recorded 
diagnosis, number and type of mood episodes, Care Programme Approach (CPA) 
status, number of voluntary and involuntary psychiatric admissions, history of 
psychotic symptoms, history of self-harm, history of substance use and associations 
with mood episodes, urine drug test results recorded during admissions, current and 
previous medication history.  
Cohort 2 
The French retrospective bipolar disorder lifetime descriptive case series was used to 
identify and characterise people with a DSM-IV diagnosis of bipolar I disorder who fulfil 
unipolar mania criteria. This cohort has been fully described by Drancourt and 
colleagues (Drancourt et al., 2013). Briefly, the cohort comprises Caucasian French 
individuals who met DSM-IV criteria for bipolar I or II disorder recruited from three 
general adult psychiatry follow-up clinics. This study was approved by the Comité de 
Protection des Personnes from La Pitié-Salpétrière Hospital (reference: P111002-
IDRCB2008-AO1465-50) in Paris, France. All participants provided written informed 
consent prior to inclusion. This study was primarily designed to identify genetic and 
environmental risk factors in bipolar disorder (ClinicalTrials.gov Identifier: 
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NCT02627404). Each participant was assessed by a trained psychiatrist using the 
Diagnostic Interview for Genetic Studies, a structured schedule that provides a 
retrospective lifetime description of bipolar disorder and other axis I disorders, and this 
was supplemented by detailed recording of treatment history. People with a diagnosis 
of bipolar II disorder, those with a diagnosis of bipolar I disorder with a lifetime history 
of two or less manic episodes and no depressive episodes, and those with less than 
10 years duration of illness were excluded. The remaining patients were either patients 
with a lifetime history of at least three manic episodes but no depressive or mixed 
episodes (unipolar mania group) or those with a lifetime history of at least one 
depressive and manic episode (bipolar group). The following variables were extracted 
for individuals identified within the cohort: age, gender, age at onset, duration of illness 
from first mood episode, number of manic episodes, number of hypomanic episodes, 
number of major depressive episodes number of hospitalizations, number of suicide 
attempts, psychotic symptoms at onset of illness, any experience of psychotic 
symptoms, history of cannabis misuse, history of any substance misuse, history of any 
anxiety disorder. 
Statistical analysis 
Differences in continuous variables between groups were examined using t-tests and 
are reported as mean ± standard deviation. Differences in categorical data were 
analysed using Chi squared or Fishers exact test when expected counts were less 
than five. Given the exploratory nature of this study, the statistical threshold used was 
p<0.05 uncorrected for multiple comparisons. All statistical analyses were performed 
using SPSS (SPSS, Chicago, Illinois, USA). 
Results 
Cohort 1 
The initial CRIS search identified 2920 people with a diagnosis of bipolar disorder, 
mania or hypomania and no previous documented episodes of depression. 2360 
people were excluded as they had a follow-up duration of less than ten years leaving 
560 potentially suitable people. Of these, 15 survived the exclusion process. 513 
people were excluded because of a reference to a major depressive episode or 
depressive symptoms in the search of case records, 12 were excluded because of a 
primary diagnosis other than bipolar disorder (schizophrenia, schizoaffective disorder, 
learning disability, substance use disorder), and 20 because of insufficient clinical 
information. During the matching process, 2 additional people with unipolar mania 
were identified and the final sample consisted of 17 people with unipolar mania (see 
Figure 1). 
INSERT FIGURE 1 HERE PLEASE 
The CRIS search for bipolar I disorder patients who could be possible matches to the 
unipolar mania group identified 6637 people, 1458 of who had at least a 10-year 
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clinical follow-up (see Figure 2). The mean age of this bipolar clinical population was 
54.3±14.5 years, 569 men (39%) and 889 women (61%). The unipolar mania group 
did not differ in gender compared to people with bipolar I disorder with at least 10 years 
of clinical follow-up (unipolar mania 59% male, bipolar disorder 39% male, p<0.1) but 
they did have a significantly different ethnicity profile with 59% of the unipolar mania 
group being African in ethnicity and 12% being British, compared to 6% and 52% for 
the overall South London bipolar population (p<0.001).  
INSERT FIGURE 2 HERE PLEASE  
The unipolar mania and matched bipolar groups were well matched for age (mean age 
unipolar mania 49 ± 11, mean age bipolar disorder 49 ± 10, p= 0.97), gender (10 males 
in each group), and ethnicity (unipolar mania: 10 African-Caribbean, 1 Other Black, 3 
Asian, 1 Mixed, 2 British; bipolar disorder: 8 African-Caribbean, 3 Other Black, 3 Asian, 
1 Mixed, 2 British; p=0.96). People with unipolar mania experienced significantly more 
manic episodes than the bipolar disorder group (unipolar mania 7.4±4.5, bipolar 
disorder 4.3±2.0, p=0.017) and experienced significantly fewer recorded hypomanic 
episodes (unipolar mania 0, bipolar disorder 0.6±1.2, p=0.036) (See Table 1 and 
Figure 3). Both groups experienced a similar number of total mood episodes (unipolar 
mania 7.4±4.5 episodes, bipolar disorder 9.6±4.4 episodes, p=0.15). There were no 
differences between the two groups in age of onset, duration of illness, history of self-
harm, history of suicide attempts, or the number or type of psychiatric hospital 
admissions. There were also no differences in substance use or anxiety disorders or 
medical illness co-morbidities. People with unipolar mania did not differ from people 
with bipolar disorder in their current or lifetime histories of treatment with 
antipsychotics (typical or atypical), mood stabilisers, long acting injectable 
antipsychotics, number of psychiatric medications currently taken or number of people 
not currently taking any psychiatric medications.  
INSERT TABLE 1 AND FIGURE 3 HERE PLEASE 
Cohort 2 
392 patients with bipolar I disorder were identified from the French sample, and of 
these 13 fulfilled unipolar Mania criteria and 379 experienced at least one depressive 
episode. The demographic, clinical and treatment characteristics of these two groups 
are shown in Table 2.  
INSERT TABLE 2 HERE PLEASE 
There was no significant difference between the unipolar mania and bipolar groups in 
age or gender. People with unipolar mania experienced significantly more manic 
episodes (unipolar mania 6.5±4.3, bipolar disorder 2.6±2.4, p=0.0001) but did not 
experience more hypomanic episodes (unipolar mania 5.6 ± 7.2, bipolar disorder 1.5 
± 2.8, p=0.29) (See Figure 2). There were no differences between groups in the total 
number of major mood episodes experienced (unipolar mania 6.5 ± 4.3 episodes, 
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bipolar disorder 6.5 ± 4.1 episodes, p=0.99). People with unipolar mania were more 
likely to experience psychotic symptoms during their first mood episode (unipolar 
mania 62%, bipolar disorder 22%, p=0.003). There were no differences between the 
two groups in age of onset, duration of illness, history of psychosis, history or number 
of suicide attempts. People with unipolar mania experienced significantly more 
psychiatric hospital admissions (unipolar mania 8.0±6.4, bipolar disorder 4.1±4.2, 
p=0.007). There were no differences in anxiety or addictions co-morbidity between the 
two groups.  
People with unipolar mania were significantly less likely to have lifetime history of 
antidepressant (unipolar mania 25%, bipolar disorder 90%, p=0.0001) or 
benzodiazepine (unipolar mania 55%, bipolar disorder 87%, p=0.009) treatment. 
There were no differences in lifetime history of treatment with atypical or typical 
antipsychotics; lithium, valproate or carbamazepine mood stabilisers; receiving 
combinations of mood stabilisers or receiving electroconvulsive therapy.  
Discussion 
In this study, we identified and characterised 30 people with unipolar mania in the 
United Kingdom and France. In the UK South London group, we identified 17 people 
with bipolar disorder who, over a ten-year follow-up period, have only experienced 
manic episodes and did not experience any documented depressive episodes. In the 
French group, we identified 13 people with bipolar disorder who from their semi-
structured psychiatric assessment had only experienced manic or hypomanic 
episodes for at least 10 years and had never experienced a major depressive episode. 
Our study is the first to identify and characterise people with unipolar mania in the 
United Kingdom and only the second to do so in France.   
The frequency of unipolar mania as a percentage of the bipolar disorder population 
was broadly similar in the two cohorts; 1.2% (17/1458) for the South London cohort 
and 3.3% (13/392) for the French cohort. We would speculate that, given the potential 
difficulties in identifying patients with unipolar mania in electronic clinical case records, 
the true frequency of unipolar mania as a percentage of the bipolar population in South 
London is likely to be higher. The rates of unipolar mania in the bipolar disorder 
population identified from our study is similar to the 5% rate reported in the USA (Baek 
et al., 2014), using similar unipolar mania criteria to ours, and to the 8.7% rate reported 
in Switzerland (Angst et al., 2004). It is however markedly lower than the 21% rate 
reported by Perugi et al. in an Italian inpatient bipolar sample (Perugi et al., 2007). 
This difference may be due to differences in exclusion criteria, for example the Perugi 
et al. study included people who had experienced a mixed episode as unipolar mania 
cases whereas ours excluded them. This underlines the need to develop a widely 
accepted clinical criteria for unipolar mania. Our study reinforces that people with 
unipolar mania can be identified in European countries and our findings suggest that 
people with unipolar mania may make up around 3% of the population of people with 
bipolar disorder in the UK and France.  
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Our results add to the evidence that the prevalence of unipolar mania amongst people 
with bipolar disorder is significantly lower in developed countries compared to 
developing countries. For example, our results contrast markedly to studies from 
Tunisia, Fiji, India and Nigeria which, using similar unipolar mania criteria to ours,  
report that at least 40% of people with bipolar disorder fulfilled criteria for unipolar 
mania (Aghanwa, 2001; Dakhlaoui et al., 2008; Khanna et al., 1992; Makanjuola, 
1985). We also found interesting differences in the ethnicity of people with unipolar 
mania in South London compared to the bipolar disorder population, with a higher 
frequency than expected of people with unipolar mania of African ethnicity and lower 
frequency of white British ethnicity, albeit within a small sample size. This finding is 
similar to those reported by Baek et al in the United States who found that unipolar 
mania was more common in non-white people (Baek et al., 2014). We would suggest 
that future studies investigate differences in the prevalence of unipolar mania between 
developed and developing countries, and the potential role of ethnicity factors in 
mediating unipolar mania. 
This study identified differences in the clinical characteristics of people with unipolar 
mania compared to people with bipolar disorder who have experienced depressive 
episodes. A clear finding from both cohorts was that people with unipolar mania 
experienced more manic episodes, 1.7 times more episodes in the UK cohort and 2.5 
times more episodes in the French cohort, even though there were no differences 
between groups in the total overall number of mood episodes experienced (mania, 
hypomania, mixed and depressive). Our finding of an increased frequency of manic 
episodes experienced by people with unipolar mania has been previously reported by 
several other studies (Baek et al., 2014; Perugi et al., 2007). In contradiction to our 
hypothesis, we found no difference in the age of onset of bipolar disorder experienced 
by people with unipolar mania compared to people with bipolar disorder who have 
experienced depression in either cohort. People with unipolar mania in the French 
cohort were around three times more likely to experience psychotic symptoms during 
their first manic episode than people with bipolar disorder who have experienced 
depression. This finding concords with previous studies which report that people with 
unipolar mania are more likely to experience a psychotic illness onset (Andrade-
Nascimento et al., 2011; Yazici et al., 2002). We were not able to examine this in the 
UK cohort as all first manic episodes in this cohort occurred before the inception date 
of the electronic clinical record system in 2005/6 which meant that there was often a 
limited clinical description available from uploaded previous records. There was 
however no increase in either cohort of the numbers of people with unipolar mania 
who had a lifetime history of psychosis compared to people with bipolar disorder who 
have experienced depressive episodes. People with unipolar mania in the French 
cohort also experienced more psychiatric hospital admissions but this finding was not 
replicated in the UK cohort potentially because of differences in mental health service 
provision between the two countries. 
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We found no differences in the self-harm risk profiles, or rates of substance use 
disorder and anxiety disorder co-morbidities in people with unipolar mania compared 
to people with bipolar disorder who had experienced depressive episodes. Importantly, 
the lack of association between substance use and unipolar mania implies that 
unipolar mania is not mediated by increased rates of the use of stimulants or other 
drugs which may induce mania. There was also no evidence in either cohort that 
people with unipolar mania were significantly less likely have a history of suicide 
attempts. This finding is similar to that reported by Perugi et al (Perugi et al., 2007) 
and may not support the concept that people with unipolar mania are at less risk of 
self-harm and suicide as they do not experience depressive episodes. These findings 
should to be considered in the context of the small unipolar mania sample size which 
may have been underpowered to detect relatively rare events such as suicide 
attempts. 
Although we found clear differences in the clinical characteristics between the unipolar 
mania and bipolar disorder groups, their treatment characteristics were broadly similar. 
We found no differences between the two groups in antipsychotic treatment history, 
lithium or other mood stabiliser treatment history, or a history of combinations of mood 
stabilisers and antipsychotics. The main exception was that people with unipolar 
mania were significantly less likely to be treated with antidepressants, which would be 
expected as they have not experienced depressive episodes, and the French cohort 
were significantly less likely to be treated with benzodiazepines. As we found no major 
differences in the principal pharmacological treatment approaches for bipolar disorder 
between the two groups this may imply that unipolar mania is not a consequence of 
lack of appropriate treatment.   
Limitations and strengths 
A key strength of this study is that we identified people with unipolar mania who had 
experienced a very long duration of illness; in the UK cohort the mean duration was 
approximately 20 years and in the French cohort it was 23 years. This addresses the 
concern that depressive episodes may be missed in this population due to insufficient 
longitudinal observation. We also applied a very strict unipolar mania criteria including 
only people who had experienced at least three manic episodes and excluding people 
who had experienced any depressive or mixed episodes. Our study also identified and 
characterised people with unipolar mania in two geographically distinct but 
developmentally advanced Western European populations.  
There are several limitations to this study. We were only able to identify a relatively 
small number of people with unipolar mania in each cohort which limits the power of 
the study to detect differences in clinical variables. Despite this, in both cohorts we 
identified differences in the frequency of manic episodes experienced. We were also 
unable to investigate ethnicity in the French cohort as this group originated from a 
study designed to investigate the genetic and environmental risk factors of bipolar 
disorder in which all participants were Caucasian French. A small number of people 
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with unipolar mania individuals had a history of being treated with antidepressants. 
These medications may have been used to treat co-morbid anxiety symptoms rather 
than depressive symptoms and there were no documented major depressive episodes 
in either unipolar mania cohorts. Finally, given the retrospective nature of the French 
cohort, and that SLaM electronic clinical records system began in 2005/6 with some 
previous records also uploaded, depressive episodes may have been missed due to 
reporting bias. However depressive episodes were assessed using a validated semi-
structured interview in the French cohort, and uploaded records prior to 2005/6 or 
clinical references to symptoms prior to this date were searched and recorded in the 
South London study.   
Conclusions 
This study adds to the literature that people with unipolar mania can be identified in 
western developed countries at a prevalence rate of between 1-3% of the overall 
bipolar disorder population. This suggests that there are at  least 19,000 people with 
unipolar mania living in the UK or France based on a 1% prevalence rate of bipolar I 
disorder (Merikangas et al., 2007). Our study provides further evidence that people 
with unipolar mania may experience an increased frequency of manic episodes but 
does not support the notion that they experience an earlier age of onset, are more 
likely to experience a history of psychosis or are at lower risk of self-harm. We have 
shown that it is possible to identify an uncoupling of mania from depression, as has 
been suggested by Hickie and others (Hickie, 2014), in two European bipolar disorder 
populations. Our findings call for larger prospective studies of unipolar mania in 
developed countries to better define prevalence, clinical characteristics and treatment 
response.  
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